Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection

Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, View ORCID ProfileTakahiro Muro
doi: https://doi.org/10.1101/2021.07.23.21261029
Marie Suehiro
1Division of Medical Informatics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinya Okubo
2Division of Pharmaceutical Health Care and Science, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kensuke Nakajima
2Division of Pharmaceutical Health Care and Science, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kosuke Kanda
3Division of Clinical pharmaceutics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanobu Hayakawa
3Division of Clinical pharmaceutics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Oiso
2Division of Pharmaceutical Health Care and Science, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsutomu Kabashima
4Division of Pharmaceutical Technology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Fujita
5Section of Functional Morphology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukio Ando
6Division of Amyloidosis Research, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Muro
1Division of Medical Informatics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Takahiro Muro
  • For correspondence: muroth1{at}niu.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: August 2021 to June 2025

AbstractFullPdf
Aug 2021875969879
Sep 20214352160141
Oct 202130834166
Nov 2021266668
Dec 20213951464
Jan 20222511260
Feb 2022149122
Mar 202287221
Apr 202259313
May 202291316
Jun 202256019
Jul 20225218
Aug 202262319
Sep 20225029
Oct 20227107
Nov 202247110
Dec 202238210
Jan 202334311
Feb 20234536
Mar 20232201
Apr 202338215
May 20232117
Jun 20232052
Jul 20231426
Aug 202325106
Sep 20232467
Oct 202319310
Nov 202323216
Dec 20232013
Jan 20243205
Feb 202425410
Mar 20242605
Apr 20242237
May 20242054
Jun 20242047
Jul 202426410
Aug 202430919
Sep 202442912
Oct 202417610
Nov 202426215
Dec 202418411
Jan 202521913
Feb 2025232011
Mar 2025523516
Apr 2025281215
May 2025262117
Jun 202530107
Back to top
PreviousNext
Posted August 06, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, Takahiro Muro
medRxiv 2021.07.23.21261029; doi: https://doi.org/10.1101/2021.07.23.21261029
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, Takahiro Muro
medRxiv 2021.07.23.21261029; doi: https://doi.org/10.1101/2021.07.23.21261029

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)